Search for: "United States v. Schall"
Results 1 - 20
of 31
Sorted by Relevance
|
Sort by Date
19 Jun 2009, 11:15 am
Comer Today's brief is of Schall v. [read post]
28 Mar 2013, 10:06 am
Cir. 2013) Download 12-1085.Opinion.3-21-2013.1Panel: Newman (author), Lourie, Schall It's a general rule of commercial litigation in the United States that parties must bear their own legal costs. [read post]
18 Feb 2009, 8:48 am
United States, 543 F.3d 1276 (Fed. [read post]
22 Dec 2009, 10:11 am
By Dennis Crouch i4i Limited Partnership v. [read post]
12 Dec 2016, 1:47 pm
By Jason Rantanen Power Integrations, Inc. v. [read post]
10 Mar 2010, 5:26 pm
The position was previously filled by Judge Schall. [read post]
5 Sep 2007, 11:40 am
Cir. 2007) (Schall, J., dissenting-in-part). [read post]
5 Sep 2007, 11:40 am
Cir. 2007) (Schall, J., dissenting-in-part). [read post]
29 Jul 2013, 2:37 pm
The United States Court of Appeals for the Federal Circuit recently issued a decision in Novozymes v. [read post]
19 May 2016, 3:21 am
The patentability of computer-implemented inventions has been in doubt in the United States since the U.S. [read post]
5 Jun 2012, 10:47 am
In Merial Ltd. v. [read post]
2 Oct 2013, 8:58 am
On September 26, 2013, the United States Court of Appeals for the Federal Circuit issued a panel decision in Sunovion Pharmaceuticals v. [read post]
7 Jan 2017, 8:26 am
”) Schall v. [read post]
4 May 2015, 8:03 am
At the same time Stoll was appointed to the Federal Circuit, President Obama simultaneously appointed Judge Luis Felipe Restrepo of the United States District Judge in the Eastern District of Pennsylvania to serve on the United States Court of Appeals for the Third Circuit. [read post]
10 Jul 2014, 7:18 pm
USI Film Prods., 511 U.S. 244, 270–71 (1994) (collecting cases); see also United States v. [read post]
26 Oct 2014, 8:23 pm
Consideration of Hamdi v. [read post]
31 Mar 2023, 9:31 am
In response to the PHE, Secretary Azar of the Department of Health and Human Services declared that DEA-registered practitioners in all areas of the United States may issue prescriptions for all schedule II-V controlled substances to patients for whom they have not conducted an in-person medical evaluation, provided all of the following conditions are met: The prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of his/her… [read post]
7 Mar 2015, 9:26 pm
The Supreme Court recently observed this challenge to patent claim interpretation, stating in Nautilus, Inc. v. [read post]
20 May 2009, 6:47 am
" Schall v. [read post]
13 Apr 2017, 6:22 am
Noelle v. [read post]
